| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/29/2000 | US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 08/29/2000 | US6110923 Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity |
| 08/29/2000 | US6110922 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 08/29/2000 | US6110921 Administering to mammal a sustained-release microparticle comprising antipsychotic agent in biodegradable polymer matrix |
| 08/29/2000 | US6110920 Treatment of cardiovascular disorders and impotency |
| 08/29/2000 | US6110919 Diazabicyclic neurokinin antagonists |
| 08/29/2000 | US6110918 Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist |
| 08/29/2000 | US6110917 Selective serotonin (5-ht) receptor agonist for treating migraines, vasospasms |
| 08/29/2000 | US6110915 Antiemetic use of triazolo-pyridazine derivatives |
| 08/29/2000 | US6110914 Spiroazabicyclic heterocyclic compounds |
| 08/29/2000 | US6110913 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 08/29/2000 | US6110912 Administering to eye of patient a serine-threonine kinase inhibitor to enhance aqueous humor outflow |
| 08/29/2000 | US6110910 Antiinflammatory agents, antiarthritic agents, antirheumatic agents, anticarcinogenic agents |
| 08/29/2000 | US6110908 Skin sensitive mixture of antimicrobial lower alkanol, antimicrobial fatty acid or glycerol monolaurate, and zinc pyrithione |
| 08/29/2000 | US6110906 Androgen derivatives for use in the inhibition of sex steroid activity |
| 08/29/2000 | US6110905 Long-acting oxytetracycline composition |
| 08/29/2000 | US6110903 Benzimidazole inhibitors of fructose 1,6-bisphosphatase |
| 08/29/2000 | US6110900 Nucleic acid ligands |
| 08/29/2000 | US6110888 Substituted phenols as fragrance, flavor and antimicrobial compounds |
| 08/29/2000 | US6110742 Nucleotide sequences of nuclease resistant antisense agent which modulates acetylcholinesterase production in the central nervous system; treatment of alzheimer's disease with reduced side effects |
| 08/29/2000 | US6110740 Human vault RNA |
| 08/29/2000 | US6110716 HIV integrase inhibitors |
| 08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/29/2000 | US6110505 Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate |
| 08/29/2000 | US6110504 A crystalloid solution consisting of dissolved salts comprising sodium chloride, potassium chloride, calcium chloride, magnesium chloride and organic acid selected from lactate, acetate, pyruvate, gluconate, succinate, and glucose |
| 08/29/2000 | US6110503 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent |
| 08/29/2000 | US6110502 Method for producing water dispersible sterol formulations |
| 08/29/2000 | US6110499 Phenytoin therapy |
| 08/29/2000 | US6110497 Pharmaceutical formulations |
| 08/29/2000 | US6110494 The mini-tablets which release cisapride or its salt in a controlled manner in the distal regions of gastrointestinal tract have a core of cisapride or a salt embedded in a hydrophilic polymer coated with a ph dependent polymer |
| 08/29/2000 | US6110493 Terazosin capsules |
| 08/29/2000 | US6110489 Use of quinolines and quinolones to treat male erectile dysfunction |
| 08/29/2000 | US6110485 Includes a therapeutical agent and retanoid along with a carrier sized for insertion into eye tissue in which the systemic release of a therapeutical agent is desired for providing sustained or controlled release of the drug |
| 08/29/2000 | US6110478 Oral carotenoid of carotene compounds |
| 08/29/2000 | US6110477 Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use |
| 08/29/2000 | US6110475 Compostion, barrier film, and method for preventing contact dermatitis |
| 08/29/2000 | US6110471 Administering phosphodiesterase for inhibition of the cycles |
| 08/29/2000 | US6110460 Methods of using morphogen analogs |
| 08/29/2000 | US6110458 Cancer therapy utilizing ex vivo gene transduction |
| 08/29/2000 | US6110453 Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 08/29/2000 | US6110449 Antiperspirant, perfumes, cyclodextrin inclusion complex andcarriers |
| 08/29/2000 | CA2157879C Methods for inhibiting bone loss with 3,4-diarylchroman |
| 08/29/2000 | CA2086754C Treatment of human lactation failure |
| 08/29/2000 | CA2018704C N-phenylpyrazole derivatives |
| 08/29/2000 | CA2016631C Substituted aminoalkylphosphinic acids |
| 08/29/2000 | CA2012628C New fluoro-4 benzoic derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/29/2000 | CA2012081C 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives |
| 08/26/2000 | CA2298877A1 Use of mesophase-stabilized compositions for delivery of cholesterol-reducing sterols and stanols in food products |
| 08/24/2000 | WO2000049413A2 Rapid assay for arthropod-borne disease vectors and pathogens |
| 08/24/2000 | WO2000049403A1 Method for screening compound having affinity for vitamin d receptor |
| 08/24/2000 | WO2000049160A1 Phenylalanine hydroxylase gene variants, and amino acid and pterin homeostasis, in the definition, detection, treatment and prevention of psychotic, mood and personality disorders |
| 08/24/2000 | WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | WO2000049144A2 Pyk2 binding proteins |
| 08/24/2000 | WO2000049135A2 Substrate for cell growth |
| 08/24/2000 | WO2000049040A2 Antimicrobial/endotoxin neutralizing polypeptide |
| 08/24/2000 | WO2000049037A1 Growth hormone secretagogues |
| 08/24/2000 | WO2000049030A1 5-fluorouridine derivatives and anticancer agents containing the same as the active ingredient |
| 08/24/2000 | WO2000049026A1 Novel process for preparing alendronic acid |
| 08/24/2000 | WO2000049021A2 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
| 08/24/2000 | WO2000049018A1 2-amino-6-anilino-purines and their use as medicaments |
| 08/24/2000 | WO2000049015A1 Pyridine compounds and their pharmaceutical use |
| 08/24/2000 | WO2000049014A1 Process for the production of tert-butyl (e)-(6-[2- [4-(4-fluorophenyl) -6-isopropyl-2-[ methyl (methylsulfonyl) amino] pyrimidin-5-yl] vinyl](4r, 6s)-2,2-dimethyl [1,3]dioxan-4-yl) acetate |
| 08/24/2000 | WO2000049011A1 Prothease inhibitors |
| 08/24/2000 | WO2000049007A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s |
| 08/24/2000 | WO2000049005A1 Bicyclic compounds and their use as integrin receptor ligands |
| 08/24/2000 | WO2000049000A1 Dopamine d1 receptor agonist compounds |
| 08/24/2000 | WO2000048996A2 β-ALANINE DERIVATIVES |
| 08/24/2000 | WO2000048994A1 Thioamide derivatives |
| 08/24/2000 | WO2000048992A1 Acylated aminoacetonitriles as cysteine protease inhibitors |
| 08/24/2000 | WO2000048989A1 Mevinolin derivatives |
| 08/24/2000 | WO2000048988A1 Phenylalaninol derivatives |
| 08/24/2000 | WO2000048987A1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 08/24/2000 | WO2000048983A1 Soluble double metal salt of group ia and iia of (-) hydroxycitric acid |
| 08/24/2000 | WO2000048636A1 Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients |
| 08/24/2000 | WO2000048634A1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism |
| 08/24/2000 | WO2000048632A1 Novel redox clamping agents and uses thereof |
| 08/24/2000 | WO2000048631A2 Adjuvant and cell maturation agent |
| 08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | WO2000048623A1 Novel amide derivatives as growth hormone secretagogues |
| 08/24/2000 | WO2000048617A2 Connective tissue softening |
| 08/24/2000 | WO2000048610A1 Chemical compounds |
| 08/24/2000 | WO2000048609A1 Chemical compounds |
| 08/24/2000 | WO2000048608A1 Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside rb¿1? |
| 08/24/2000 | WO2000048607A1 Directly compressible matrix for controlled release of single daily doses of clarithromycin |
| 08/24/2000 | WO2000048606A1 Compositions and methods for use in targeting vascular destruction |
| 08/24/2000 | WO2000048605A1 Agent acting on the hypothalamus and the pituitary gland and having an action on the sexual cycle of domestic animals, and variants |
| 08/24/2000 | WO2000048604A1 Utilization of dienogest in high doses |
| 08/24/2000 | WO2000048603A1 DIBENZO-AZEPINE DERIVATIVES AS αV INTEGRIN RECEPTOR ANTAGONISTS |
| 08/24/2000 | WO2000048602A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 08/24/2000 | WO2000048601A1 Medicament for treating hypertension |
| 08/24/2000 | WO2000048600A1 Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism |
| 08/24/2000 | WO2000048599A1 Use of desoxypeganine in the treatment of alzheimer's dementia |
| 08/24/2000 | WO2000048598A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol |
| 08/24/2000 | WO2000048597A1 Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes |
| 08/24/2000 | WO2000048596A1 Soluble forms of amoxicillin and treatment of animals |
| 08/24/2000 | WO2000048594A1 Use of lipoic acid combination with ascorbic acid in the treatment of cancer |
| 08/24/2000 | WO2000048593A1 Epoxide hydrolase complexes and methods therewith |
| 08/24/2000 | WO2000048592A1 Essential fatty acids in the prevention of cardiovascular events |
| 08/24/2000 | WO2000048591A1 Combinations for the treatment of diseases involving angiogenesis |